Investing Ideas
/
Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential

Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with plenty of capacity to fund future growth

12 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NBIX Neurocrine Biosciences	US$145.88	2.3%	4.1%	US$14.8b	US$167.67	PE38.3x	E26.4%	n/a
INCY Incyte	US$73.47	2.1%	18.7%	US$13.9b	US$79.42	PE435.7x	E34.1%	n/a
EXEL Exelixis	US$36.43	2.2%	61.1%	US$10.3b	US$35.61	PE22.3x	E20.5%	n/a
CORT Corcept Therapeutics	US$61.11	18.3%	160.7%	US$5.8b	US$74.90	PE45.6x	E34.7%	n/a
KRYS Krystal Biotech	US$151.55	6.2%	16.2%	US$4.3b	US$206.25	PE83.2x	E36.6%	n/a
ADMA ADMA Biologics	US$16.16	-1.0%	206.6%	US$3.8b	US$24.27	PE56.1x	E26.7%	n/a
VCEL Vericel	US$59.56	1.5%	41.0%	US$2.9b	US$64.14	PE828.6x	E43.1%	n/a
HRMY Harmony Biosciences Holdings	US$40.46	11.1%	27.5%	US$2.2b	US$54.25	PE18.8x	E29.1%	n/a
LGND Ligand Pharmaceuticals	US$117.36	8.1%	59.5%	US$2.1b	US$144.00	PE49x	E26.9%	n/a
CDXC ChromaDex	US$6.09	12.1%	347.8%	US$454.7m	US$7.96	PE313.9x	E81.8%	n/a
BSEM BioStem Technologies	US$15.72	1.4%	165.1%	US$264.8m	US$32.50	PE16.5x	E33.8%	n/a
KPRX Kiora Pharmaceuticals	US$4.00	24.6%	-23.9%	US$11.7m	US$30.33	PE2.2x	E20.7%	n/a

Page 1 of 1